Clinical Trial Update: Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical imiquimod with Abraxane for advanced breast cancer has completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Skin Metastases

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Imiquimod (topical) (imiquimod)

Snippet

Sponsor: University of Washington | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-28